Amag Pharmaceuticals (33) | Business Finance (8)
Browse by Subcategory
Recent Contracts
-
Supplemental Indenture, dated as of November 16, 2020, between AMAG Pharmaceuticals, Inc. and Wilmington Trust, National Association
(Filed With SEC on November 17, 2020)
-
Asset Purchase Agreement, dated May 21, 2020, by and between AMAG Pharmaceuticals, Inc. and Millicent Pharma Limited
(Filed With SEC on May 22, 2020)
-
Form of Non-Qualified Stock Option Agreement - Non-Plan Inducement Grant
(Filed With SEC on May 11, 2020)
-
Contract Manufacturing Agreement, dated September 1, 2018, by and between AMAG Pharmaceuticals, Inc. and Fresenius Kabi Austria GmbH (Certain confidential information contained in...
(Filed With SEC on March 1, 2019)
-
Supplemental Indenture, dated as of November 16, 2020, among AMAG Pharmaceuticals, Inc., Covis Finco S. r.l. and Wilmington Trust, National Association
(Filed With SEC on November 17, 2020)
-
Supplemental Indenture, dated as of November 16, 2020, between AMAG Pharmaceuticals, Inc. and Wilmington Trust, National Association
(Filed With SEC on November 17, 2020)
-
Supplemental Indenture, dated as of November 16, 2020, among AMAG Pharmaceuticals, Inc., Covis Finco S. r.l. and Wilmington Trust, National Association
(Filed With SEC on November 17, 2020)
-
Form of Restricted Stock Unit Agreement - Non-Plan Inducement Grant
(Filed With SEC on May 11, 2020)